|
Phase II Study in Patients with Recurrent Non-Small-Cell Lung Cancer Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Phase II Study in Patients with Recurrent Non-Small-Cell Lung Cancer conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Phase II Study in Patients with Recurrent Non-Small-Cell Lung Cancer Clinical research trials and Phase II Study in Patients with Recurrent Non-Small-Cell Lung Cancer medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Phase II Study in Patients with Recurrent Non-Small-Cell Lung Cancer. Phase II Study in Patients with Recurrent Non-Small-Cell Lung Cancer Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Phase II Study in Patients with Recurrent Non-Small-Cell Lung Cancer clinical trial. Subjects often receive the most expert healthcare possible for their Phase II Study in Patients with Recurrent Non-Small-Cell Lung Cancer condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Phase II Study in Patients with Recurrent Non-Small-Cell Lung Cancer  Phase II Study in Patients with Recurrent Non-Small-Cell Lung Cancer
Phase II Study in Patients with Recurrent Non-Small-Cell Lung Cancer
For Condition: Non-Small-Cell Lung Cancer
Status: No longer recruiting
Sponsor(s): Bristol-Myers Squibb , ImClone Systems
Synopsis: To determine the tumor response rate and time to disease progression, survival and safety in the EGFR-positive, EGFR-negative and total populations.
Details:
Eligibility:
Study Type: Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria - Subjects with histologically documented recurrent or progressive NSCLC, which is either EGFR-positive or EGFR-negative by IHC (may be based on archival samples) and is metastatic - Subjects who have received one or more prior chemotherapy regimens including at least one platinum-based combination - Uni-dimensionally measurable NSCLC Exclusion Criteria - Prior major thoracic or abdominal surgery within 30 days prior to first dose of cetuximab - Prior anti-epidermal growth factor receptor antibody therapy, tyrosine kinase inhibitor, or prior chimerized or murine monoclonal antibody therapy - Prior chemotherapy within 30 days of study entry or prior radiation therapy within 3 weeks prior to first dose of cetuximab
Total Enrollment: 100
Location and Contact Information:
Mount Sinai Comprehensive Cancer Center at Aventura
Aventura, Florida, 33180
United States
Indiana Cancer Pavilion
Indianapolis, Indiana, 46202
United States
Massachusetts General Hospital
Boston, Massachusetts, 02114
United States
Washington University School of Medicine
St. Louis, Missouri, 63110
United States
Ntouch Research
South Bend, Indiana, 46628
United States
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115
United States
Mount Sinai Comprehensive Cancer Center
Miami, Florida, 33140
United States
Rush Presbyterian Hospital
Chicago, Illinois, 60612
United States
Additional Information:
Study ID Numbers: CA225-012ST;
Study Start Date: May 2003
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00063388
Other Non-Small-Cell Lung Cancer Studies:
1. Phase II Study in Patients with Recurrent Non-Small-Cell Lung Cancer
Related Studies:
Other Non-Small-Cell Lung Cancer Clinical Trials
Other Missouri Clinical Trials
Other St. Louis Clinical Trials
Phase II Study in Patients with Recurrent Non-Small-Cell Lung Cancer
|
|
|
|
|
|
|
|
